PMID- 2666453
OWN - NLM
STAT- MEDLINE
DCOM- 19890829
LR  - 20190824
IS  - 0091-2700 (Print)
IS  - 0091-2700 (Linking)
VI  - 29
IP  - 6
DP  - 1989 Jun
TI  - The monoamine oxidase inhibitor-tyramine interaction.
PG  - 529-32
AB  - Reports of hypertensive reactions from monoamine oxidase inhibitors (MAOI) began 
      to proliferate in the early 1960s. Asatoor did extensive research and found that 
      the combination of an MAOI and a food containing tyramine resulted in the 
      hypertensive interaction ("the cheese reaction"). Because of the risk of 
      intracerebral hemorrhage and death, clinicians were hesitant to use the MAOIs. 
      Although progress on the metabolic effects of MAOIs has been slow, use of 
      clinical information in addition to analysis of bioactive amine content of foods 
      has allowed the formulation of dietary recommendations, which are thought to be 
      useful clinically in the administration of MAOIs. This has resulted in the 
      gradual return to use of these psychotropic compounds.
FAU - Brown, C
AU  - Brown C
AD  - University of Tennessee, Memphis.
FAU - Taniguchi, G
AU  - Taniguchi G
FAU - Yip, K
AU  - Yip K
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - J Clin Pharmacol
JT  - Journal of clinical pharmacology
JID - 0366372
RN  - 0 (Monoamine Oxidase Inhibitors)
RN  - X8ZC7V0OX3 (Tyramine)
SB  - IM
MH  - Diet
MH  - Humans
MH  - Hypertension/*chemically induced/physiopathology
MH  - Monoamine Oxidase Inhibitors/*adverse effects
MH  - Tyramine/*adverse effects
RF  - 20
EDAT- 1989/06/01 00:00
MHDA- 1989/06/01 00:01
CRDT- 1989/06/01 00:00
PHST- 1989/06/01 00:00 [pubmed]
PHST- 1989/06/01 00:01 [medline]
PHST- 1989/06/01 00:00 [entrez]
AID - 10.1002/j.1552-4604.1989.tb03376.x [doi]
PST - ppublish
SO  - J Clin Pharmacol. 1989 Jun;29(6):529-32. doi: 10.1002/j.1552-4604.1989.tb03376.x.